Ligand Pharmaceuticals stock is on the rise with optimistic analyst ratings and a plan for 20% annual revenue growth. Learn ...

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

For the fiscal year 2024–2025, the Sun Pharma Board of Directors announced an interim dividend of Rs. 10.50/-per equity share ...

The EBITDA margin stood at 26% in the reporting quarter versus 23.1% YoY. The results came after the close of the market ...

Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter ...

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug short­ages in the U.S. and raise healthcare costs for patients, some drug trade groups warn.  They also ...

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

The consensus price target hints at a 27.1% upside potential for Amneal (AMRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate ...

The NSE Nifty 50 ended 121.10 points or 0.52% down at 23,361.05 and the BSE Sensex closed 319.22 points or 0.41% down at 77,186.74 on Monday.